NCT00523471终止不适用
Gamma-H2AX as a Molecular Predictor of Prostate Cancer Radiosensitivity
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
To check the radiosensitivity level in individual patients based on their DNA damage level.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •prostate cancer diagnosis
- •undergoing radiotherapy
- •agree to participate in study
排除标准
- •not willing to participate
- •not undergoing radiotherapy
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223Prostate AdenocarcinomaProstate CancerNCT02981797H. Lee Moffitt Cancer Center and Research Institute10
进行中（未招募）
1 期
Imaging and Genomic Biomarkers to Predict Response in Prostate CancerProstate CancerNCT05477823University of Wisconsin, Madison30
进行中（未招募）
不适用
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA TrialProstate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8NCT04624256Jonsson Comprehensive Cancer Center208
暂停
不适用
Pilot Study of Biomarkers for Radiation TherapyCancerNCT01050725Benaroya Research Institute100
已完成
不适用
RADTOX: Measuring Radiation Toxicity Using Circulating DNAProstate CancerNCT02941029University of Florida68